Strength
160 mg/mL
Manufacturer
UCB, Inc.NDC
50474078184
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2026
Active Ingredients
BIMEKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761151On Market Since
10/17/2023
Price Statistics
The NADAC for BIMZELX 160 MG/ML AUTOINJECTOR has been published 32 times since Nov 19, 2025, and over the history we have for it it has risen 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8046.4268 per ML |
|---|---|
| All-time high | $8046.4268 (Jun 24, 2026) |
| All-time low | $7616.9100 (Nov 19, 2025) |
| 52-week high | $8046.4268 |
| 52-week low | $7616.9100 |
| Median price | $8046.4268 |
| Average price | $7941.2065 |
| Largest weekly change | +5.4% (Jan 14, 2026) |
| Weeks tracked | 32 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BIMZELX 160 MG/ML AUTOINJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for BIMZELX 160 MG/ML AUTOINJECTOR, manufactured by UCB, Inc., is $8046.4268 per ML (NDC 50474078184), effective Jun 24, 2026.
How has the price of BIMZELX 160 MG/ML AUTOINJECTOR changed over time?
Over the history we have for it, the NADAC for BIMZELX 160 MG/ML AUTOINJECTOR has risen 5.6%. It has been tracked across 32 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for BIMZELX 160 MG/ML AUTOINJECTOR?
Since Nov 19, 2025, the NADAC for BIMZELX 160 MG/ML AUTOINJECTOR has ranged from a low of $7616.9100 (Nov 19, 2025) to a high of $8046.4268 (Jun 24, 2026), with a median of $8046.4268 per ML.
Are there cheaper alternatives to BIMZELX 160 MG/ML AUTOINJECTOR?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BIMZELX 160 MG/ML AUTOINJECTOR, but none are currently priced below it.
Who manufactures BIMZELX 160 MG/ML AUTOINJECTOR?
BIMZELX 160 MG/ML AUTOINJECTOR (NDC 50474078184) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification